Risk Factors for Metastatic Castration-Resistant Prostate Cancer (CRPC) Predict Long-Term Treatment with Docetaxel

• Takashi Kawahara,

  Affiliation Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan

  ⨯
• Yasuhide Miyoshi,

  Affiliation Department of Urology, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan

  ⨯
• Zenkichi Sekiguchi,

  Affiliation Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan

  ⨯
• Futoshi Sano,

  Affiliation Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan

  ⨯
• Narihiko Hayashi,

  Affiliation Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan

  ⨯
• Jun-ichi Teranishi,

  Affiliation Department of Urology, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan

  ⨯
• Hiroshi Misaki,

  Affiliation Department of Urology, Yamato City Hospital, Yamato, Kanagawa, Japan

  ⨯
• Kazumi Noguchi,

  Affiliation Department of Urology, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan

  ⨯
• Yoshinobu Kubota,

  Affiliation Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan

  ⨯
• Hiroji Uemura

  * E-mail: hu0428@med.yokohama-cu.ac.jp

  Affiliation Department of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan

  ⨯